{"a":[{"_":"CEPI-backed Ebola vaccine set to enter phase 1 trials","$":{"href":"/research/cepi-backed-ebola-vaccine-set-enter-phase-1-trials","hreflang":"en"}}]}

Phase 1Bundibugyo Ebola VaccinePositive

AI Analysis

Summary

A CEPI-backed vaccine against the Bundibugyo ebola virus is set to enter phase 1 clinical trials, marking the first vaccine candidate for this specific ebola virus strain.

Clinical Trial Data

Phase

Phase 1

Importance:5/10

Sentiment:

0.60

vaccineebolaclinical trialphase 1

Related Companies

$TRAX

Read the original article

Published by FierceBiotech on July 13, 2026 10:19 PM

Read Original